View in EDS HTML Full Text PDF Full Text

Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".

Saved in:
Bibliographic Details
Title: Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".
Authors: Durrani K; a Division of Ophthalmology , University of Connecticut Health , Farmington , Connecticut , USA., Kempen JH; b Department of Ophthalmology , Massachusetts Eye and Ear Infirmary , Boston , Massachusetts , USA.; c Department of Ophthalmology , Harvard Medical School , Boston , Massachusetts , USA.; d Discovery Eye Center , MyungSung Christian Medical Center and MyungSung Medical School , Addis Ababa , Ethiopia., Foster CS; c Department of Ophthalmology , Harvard Medical School , Boston , Massachusetts , USA.; e Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.; f Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.
Corporate Authors: Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group
Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2019; Vol. 27 (1), pp. 71. Date of Electronic Publication: 2017 Oct 18.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29043914
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Durrani+K%22">Durrani K</searchLink>; a Division of Ophthalmology , University of Connecticut Health , Farmington , Connecticut , USA.<br /><searchLink fieldCode="AU" term="%22Kempen+JH%22">Kempen JH</searchLink>; b Department of Ophthalmology , Massachusetts Eye and Ear Infirmary , Boston , Massachusetts , USA.; c Department of Ophthalmology , Harvard Medical School , Boston , Massachusetts , USA.; d Discovery Eye Center , MyungSung Christian Medical Center and MyungSung Medical School , Addis Ababa , Ethiopia.<br /><searchLink fieldCode="AU" term="%22Foster+CS%22">Foster CS</searchLink>; c Department of Ophthalmology , Harvard Medical School , Boston , Massachusetts , USA.; e Massachusetts Eye Research and Surgery Institution , Waltham , Massachusetts , USA.; f Ocular Immunology and Uveitis Foundation , Waltham , Massachusetts , USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Systemic+Immunosuppressive+Therapy+for+Eye+Diseases+%28SITE%29+Research+Group%22">Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229312169%22">Ocular immunology and inflammation</searchLink> [Ocul Immunol Inflamm] 2019; Vol. 27 (1), pp. 71. <i>Date of Electronic Publication: </i>2017 Oct 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9312169 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-5078 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209273948%22">09273948 </searchLink><i>NLM ISO Abbreviation: </i>Ocul Immunol Inflamm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29043914
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09273948.2017.1379545
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 71
    Titles:
      – TitleFull: Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Durrani K
      – PersonEntity:
          Name:
            NameFull: Kempen JH
      – PersonEntity:
          Name:
            NameFull: Foster CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1744-5078
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Ocular immunology and inflammation
              Type: main
ResultId 1